A Tough Pill to Swallow - Drug Discovery INFOGRAPHIC | JP Science Marketing

A Tough Pill to Swallow - Drug Discovery INFOGRAPHIC | JP Science Marketing

Growing importance of orphan drugs.

Growing importance of orphan drugs.

There's a lot of implicit acknowledgement of the growing importance of stakeholders in pharmaceutical but often it's neither cohesive nor patient-centric. How can patient centricity constitute a commercial model that enhances revenue potential. Rao.

There's a lot of implicit acknowledgement of the growing importance of stakeholders in pharmaceutical but often it's neither cohesive nor patient-centric. How can patient centricity constitute a commercial model that enhances revenue potential. Rao.

Deloitte | DeloitteHealth | 2015 Global Life Sciences Outlook Infographic | #CHSBlog

Deloitte | DeloitteHealth | 2015 Global Life Sciences Outlook Infographic | #CHSBlog

FirstWord Lists – Pharma's biggest growth drivers - FirstWord Pharma

FirstWord Lists – Pharma's biggest growth drivers - FirstWord Pharma

Global pharma spend to 2016. The major growth area will be in generics, which are forecast to rise from 57 per cent of the total spend on medicines in emerging markets in 2011 to 65 per cent in 2016, while branded products will shrink from 30 to 24 per cent of the market. Generics will account for 83 per cent of overall growth. http://blogs.r.ftdata.co.uk/beyond-brics/files/2012/07/IMS_41.png

Global pharma spend to 2016. The major growth area will be in generics, which are forecast to rise from 57 per cent of the total spend on medicines in emerging markets in 2011 to 65 per cent in 2016, while branded products will shrink from 30 to 24 per cent of the market. Generics will account for 83 per cent of overall growth. http://blogs.r.ftdata.co.uk/beyond-brics/files/2012/07/IMS_41.png

Taking Flight: Pharm Exec's Top 50 Pharma Companies 2015 | Pharmaceutical Executive

Taking Flight: Pharm Exec's Top 50 Pharma Companies 2015 | Pharmaceutical Executive

Pinterest
Search